Clinical Trials on Lung Adenocarcinoma

Total 63436 results

Zhejiang Cancer Hospital

Recruiting

Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma

Bile Duct Adenocarcinoma

China
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma (CHIPASTIN)

Fallopian Tube Adenocarcinoma | Ovarian Adenocarcinoma | Primary Peritoneal Carcinoma

France
Blood Transfusion Centre of Slovenia
University Medical Centre Ljubljana

Unknown

Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer (GEMSTHER)

Pancreatic Tubular Adenocarcinoma

Slovenia
Institut für Klinische Krebsforschung IKF GmbH...
Gilead Sciences

Recruiting

Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma

Esophagogastric Adenocarcinoma

Germany, Austria
Fujian Medical University Union Hospital

Recruiting

Personalized Optimization of Systematic Prostate Biopsy

Prostate Adenocarcinoma

China
University of California, Irvine
Natera, Inc.

Not yet recruiting

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Gastroesophageal Adenocarcinoma

United States
West Virginia University

Recruiting

Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

Gallbladder Adenocarcinoma

United States
Baylor Research Institute

Not yet recruiting

Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

Pancreatic Adenocarcinoma

United States
Centre Leon Berard

Recruiting

Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma (PREFAcE)

Prostate Adenocarcinoma

France
University Health Network, Toronto

Recruiting

Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study (MOCHA)

Esophagogastric Adenocarcinoma

Canada
Zhejiang Cancer Hospital

Recruiting

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Gastric Adenocarcinoma

China
University of Louisville

Recruiting

Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Canadian Cancer Trials Group
AstraZeneca

Active, not recruiting

Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Canada
Federation Francophone de Cancerologie Digestive

Completed

Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma . (REGOLD)

Colorectal Adenocarcinoma

France
Institut Curie

Completed

Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma (FibroRect)

Rectum Adenocarcinoma

France
University of Florida
Ipsen

Active, not recruiting

A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Anwaar Saeed
Actuate Therapeutics Inc.; Incyte Corporation

Active, not recruiting

9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

Pancreatic Adenocarcinoma

United States
Karolinska Institutet
Karolinska University Hospital

Terminated

Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Sweden
Innovent Biologics (Suzhou) Co. Ltd.

Terminated

A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)

Gastric Adenocarcinoma

China
Centre Hospitalier Departemental Vendee

Completed

PAncreatic Adenocarcinoma in Hospital (APACH)

Pancreatic Adenocarcinoma

France, Belgium
University of Louisville
Nestlé

Terminated

Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)

Pancreatic Adenocarcinoma

United States
Amany sayed Abass

Unknown

Role of Neoadjuvent Radiotherapy in Locally Advanced Cancer Rectum

Rectal Adenocarcinoma

Egypt
Fujian Cancer Hospital

Withdrawn

Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

China
Abramson Cancer Center of the University of Pennsylvania

Completed

A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Nintedanib in Patients With Advanced Esophagogastric Cancer

Esophagogastric Adenocarcinoma

United States
Gilead Sciences

Terminated

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Gastric Adenocarcinoma

Japan
Arog Pharmaceuticals, Inc.

Completed

Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma

Esophagogastric Adenocarcinoma

United States
Samsung Medical Center

Completed

Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy

Gastric Adenocarcinoma

Korea, Republic of
The University of Texas Health Science Center,...

Completed

Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Washington University School of Medicine

Completed

Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma

Adenocarcinoma Pancreas

United States
University of Roma La Sapienza

Completed

Role of Low Inferior Mesenteric Artery Ligation During Laparoscopic Surgery for Rectosigmoid Cancer

Rectosigmoid Adenocarcinoma

Italy
Bezmialem Vakif University

Completed

Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma

Gastric Adenocarcinoma

Turkey
Olympus Corporation
Mayo Clinic; The University of Texas Health Science Center, Houston; Kyushu University

Completed

Pancreatic Juice Diagnosis From Duodenum

Pancreatic Adenocarcinoma

United States, Japan
University of Chicago

Completed

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Herbert Hurwitz
Genentech, Inc.; Novartis Pharmaceuticals

Completed

Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus (BEV/EV)

Colorectal Adenocarcinoma

United States
Translational Oncology Research International
Sanofi; University of California, Los Angeles; OSI Pharmaceuticals

Completed

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Unresectable Adenocarcinoma of the Esophagus | Metastatic Adenocarcinoma of the Esophagus | Unresectable Adenocarcinoma of Gastric Cardia | Metastatic Adenocarcinoma of Gastric Cardia

United States
Canadian Cancer Trials Group
Jazz Pharmaceuticals

Recruiting

Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

Gastroesophageal Adenocarcinoma

Canada
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II): (SCORPIO)

Gastroesophageal Adenocarcinoma
Royal Marsden NHS Foundation Trust

Recruiting

Dose De-escalation in Prostate Radiotherapy Using the MRL (DESTINATION)

Prostate Adenocarcinoma

United Kingdom
Hamilton Health Sciences Corporation

Recruiting

Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery (PANCREAS)

Pancreatic Adenocarcinoma

Canada
Hôpital Fribourgeois

Recruiting

The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

Switzerland
Zhejiang Cancer Hospital

Recruiting

Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study

Gastric Adenocarcinoma

China
Yonsei University

Recruiting

Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

Gastric Adenocarcinoma

Korea, Republic of
Benaroya Research Institute

Recruiting

Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology

Pancreatic Adenocarcinoma

United States
Federation Francophone de Cancerologie Digestive

Recruiting

Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over (ADAGE)

Colonic Adenocarcinoma

France
University of Kansas Medical Center

Terminated

Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the Prostate (PORT-MAP)

Prostate Adenocarcinoma

United States
Weill Medical College of Cornell University
Bristol-Myers Squibb

Active, not recruiting

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Gastroesophageal Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center
Integra LifeSciences Corporation

Completed

Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material

Esophageal Adenocarcinoma

United States
Hellenic Cooperative Oncology Group
Eli Lilly and Company; Celgene Corporation

Completed

RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma (RACING)

Pancreatic Adenocarcinoma

Greece
Groupe Hospitalier Paris Saint Joseph

Active, not recruiting

Clinical, Histological and Prognostic Forms of Adenocarcinoma of the Anus (ProCHADA)

Anal Adenocarcinoma

France

3

Subscribe